ISRG
NASDAQ
Health Care
$345.42
USD
-$56.91 (-14.15%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$129.04B
Volume:
11.5M
Previous Close
$402.33
Day Range
$344.55 - $367.74
52 Week Range
$344.55 - $603.88
Average Volume (10 Days)
3.2M
P/E Ratio (TTM)
43.32
Dividend Yield
—
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. The company is headquartered in Sunnyvale, California and currently employs 17,021 full-time employees. The company went IPO on 2000-06-13. The firm specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
CEO
Mr. David Rosa
Headquaters
Sunnyvale, CALIFORNIA, US
Founded
2000
Employees
17,021
Intuitive Surgical reported Q2 revenue of $2.89 billion (up 19% year-over-year) and adjusted EPS of $2.80, both exceeding analyst estimates. However, shares fell sharply as US procedure growth slowed to 12% from 14% in the prior quarter, and management guided full-year da Vinci procedure growth closer to 14.5%, below analyst expectations of roughly 15.3%.
0
0
Medtronic received CE mark approval for its Stealth AXiS surgical system, a next-generation robotic platform for spine and cranial procedures that integrates navigation, planning, and robotics. The approval represents competitive advancement in surgical robotics, a space where Intuitive Surgical has traditionally dominated with its da Vinci systems.
0
0